Prevalence of metabolic syndrome in a hemodialysis population

Iranian Journal of Kidney Diseases

Volumn 5, Issue 4, 2011, Pages 248-254

  Jalalzadeh, Mojgan ^a   Mohammadi, Ramin ^a   Mirzamohammadi, Fatemeh ^a   Ghadiani, Mohammad Hassan ^b  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemodialysis; Hypertension; Metabolic syndrome X

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROGNOSIS; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 79959855103     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005;51:931-8.
2. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333-45.
3. [No author listed]. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
4. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444-9.
5. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365:1398-405.
6. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066-76.
7. Scott CL. Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol. 2003;92:35i-42i.
8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
9. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-36.
10. Anand SS, Yi Q, Gerstein H, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation. 2003;108:420-25.
11. Joshy G, Simmons D. Epidemiology of diabetes in New Zealand: Revisit to a changing landscape. N Z Med J. 2006;119:U1999.
12. Reynolds K, He J. Epidemiology of the metabolic syndrome. Am J Med Sci. 2005;330:273-9.
13. [No author listed]. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
14. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med. 2004;140:167-74.
15. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
16. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 2002;288:2709-16.
17. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769-78.
18. Segura J, Campo C, Roldan C, et al. Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances. J Am Soc Nephrol. 2004;15:s37-42.
19. Young DO, Lund RJ, Haynatzki G, Dunlay RW. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int. 2007;11:86-95.
20. Armstrong KA, Hiremagalur B, Haluska BA, et al. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation. 2005;80:937-44.
21. Armstrong KA, Campbell SB, Hawley CM, Nicol DL, Johnson DW, Isbel NM. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant. 2005;5:2710-18.
22. Elsaid SA, Hamada MA, Alsaran KA. Obesity and metabolic syndrome in Saudi hemodialysis patients. JNRT. 2009;2:18-27.
23. Stoli R, Trajkovi G, Peri V, et al. Frequency and characteristics of metabolic disorders in patients on haemodialysis. Vojnosanit Pregl. 2008;65:205-9.
24. Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21-8.
25. Williams JD, Woods HF. Insulin Resistance, the Metabolic Syndrome and Renal Failure - Is There a Special Problem for Patients Treated with Peritoneal Dialysis? Eur Endocrine Rev. 2006;15:54-9.
26. Bakker SL, Gansevoort RT, Zeeuw DD. Metabolic syndrome: a fata morgana? Nephro Dial Transplant. 2007;22:15-20.
27. Zhang R, Liao J, Morse S, Donelon S, Reisin E. Kidney disease and the metabolic syndrome. Am J Med Sci. 2005;330:319-25.
28. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among non-diabetic adults. J Am Soc Nephrol. 2005;16:2134-40.
29. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369-74.
30. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63: 793-808.
31. Johnson DW, Armstrong K, Campbell SB, et al. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology. 2007;12:391-8.